RVMD — REVOLUTION MEDICINES

Ownership history in GENERAL ATLANTIC, L.P.  ·  2 quarters on record

This page tracks every 13F SEC filing in which GENERAL ATLANTIC, L.P. reported a position in REVOLUTION MEDICINES (RVMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
7.8% (2025 Q4)
Avg. % of fund
5.63%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 2,812,928 +338,500 +13.7% 7.80% $224.0M $79.65
2025 Q3 INITIATED 2,474,428 — — 3.47% $115.6M $46.70
% of Fund (quarterly)    RVMD price (monthly, adj. close)

Other funds also holding RVMD

As of 2025 Q4 — sorted by position size

AIHC Capital Management Ltd 67.21% Park Avenue Institutional Advisers LLC 3Y 7Y 40.5% Paradigm Biocapital Advisors LP 3Y 13.51% Casdin Capital, LLC 3Y 7Y 12.75% DAFNA Capital Management LLC 3Y 7Y 11.18% Alphabet Inc. 3Y 10.33% Logos Global Management LP 3Y 9.63% Checkpoint Capital L.P. 9.21% MIC Capital Management UK LLP 3Y 9.18% BVF INC/IL 3Y 7Y 9.0%
← Back to GENERAL ATLANTIC, L.P. Holdings